3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer
Many income investors probably have mixed emotions about stocks with ultra-high dividend yields. On one hand, they love the tremendous income these stocks provide. On the other hand, they might worry more often than not about a potential dividend cut.
(NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many income investors, questions about the sustainability of the dividend persist.
But there's good news for income investors following Pfizer's second-quarter update on Aug. 5. Here are three reasons Pfizer's juicy dividend is getting safer.
Source Fool.com
Pfizer Inc. Stock
€21.74
-3.400%
With 15 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 27 € there is a positive potential of 24.22% for Pfizer Inc. compared to the current price of 21.74 €.
